SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar jemsa (< 20) Submitted: 11/22/2010 3:35:55 PM : Outperform Start Price: $3.83 SCLN Score: +40.62

lowpricevaluestocks15

Featured Broker Partners


Advertisement